In summary, our data indicated that bilateral rTMS ameliorated depression via the improvement of sleep disorders in MDD, and ACTH concentration in blood is a biomarker to predict the efficacy of rTMS in male patients with MDD. The gene discussed is POMC; the disease is major depressive disorder.